Company Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases.
Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings.
Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.
Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
| Country | United States |
| Founded | 1956 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 125,000 |
| CEO | Marc Casper |
Contact Details
Address: 168 Third Avenue Waltham, Massachusetts 02451 United States | |
| Phone | 781 622 1000 |
| Website | thermofisher.com |
Stock Details
| Ticker Symbol | TMO |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000097745 |
| CUSIP Number | 883556102 |
| ISIN Number | US8835561023 |
| Employer ID | 04-2209186 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Marc N. Casper | Chairman and Chief Executive Officer |
| Gianluca Pettiti | President and Chief Operating Officer |
| Stephen Williamson | Senior Vice President and Chief Financial Officer |
| Michel Lagarde | Executive Officer |
| Joseph R. Holmes | Vice President and Chief Accounting Officer |
| Ryan J. Snyder | Senior Vice President and Chief Information Officer |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer |
| Rafael Tejada | Vice President of Investor Relations |
| Thomas Bailey Shropshire Jr. | Senior Vice President and General Counsel |
| Sandy B. Pound | Vice President and Chief Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 11, 2026 | 144 | Filing |
| Mar 5, 2026 | 144 | Filing |
| Mar 4, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 12, 2026 | 8-K | Current Report |
| Feb 10, 2026 | 424B5 | Filing |
| Feb 9, 2026 | FWP | Free Writing Prospectus |
| Feb 9, 2026 | 144 | Filing |